
Esprit Pharma India Private Limited
Founded in 2011 and headquartered in Tamil Nadu, India.
Founded in 2011 and headquartered in Tamil Nadu, India.
Salem, Tamil Nadu, India
+91-XXXXXXXXXX
U24230TZ2011PTC017345
017345
Private Limited Indian Non-Government Company
18 Aug 2011
30 Sep 2013
31 Mar 2013
Unlisted
Roc Coimbatore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sivanesan Mani ![]() | Director | 18-Aug-2011 | Current |
Rajanbabu Priyadharsini ![]() | Director | 18-Aug-2011 | Current |
Enhance accessibility to Esprit Pharma India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Esprit Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Esprit Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Esprit Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esprit Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Esprit Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records.
Esprit Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Coimbatore.
Sivanesan Mani was appointed as a Director was appointed as a Director on 18 Aug 2011 & has been associated with this company since 13 years 7 months .
Rajanbabu Indra Priyadharsini was appointed as a Director was appointed as a Director on 18 Aug 2011 & has been associated with this company since 13 years 7 months .
Esprit Pharma India Private Limited was registered on 18 Aug 2011 with Roc Coimbatore & aged 13 years 7 months as per MCA records.
Esprit Pharma India Private Limited was incorporated on 18 Aug 2011.
The authorized share capital of Esprit Pharma India Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.20 M.
Currently 2 directors are associated with Esprit Pharma India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Esprit Pharma India Private Limited is New No: 1/12 Sriram Nagar Second Street, Five Roads India, Salem, Tamil Nadu, 636016.
The corporate identification number (CIN) of Esprit Pharma India Private Limited is U24230TZ2011PTC017345 and the company number is 017345 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Esprit Pharma India Private Limited was filed with the ROC on 31 Mar 2013.
Search company & director profiles for free and gain access to critical business data.